AVDL Avadel Pharmaceuticals plc Ordinary Share

XNAS 21.66 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

AVDL $21.66 —
Key stats
$21.66
52-Week Range
$18.68 – $23.57
YTD
+0.65%
IV Rank (30D)
33.01
Straddle Price
$4.00
P/C Vol Ratio
0.03
Market Cap
$2.1B
Open
$21.66
Day Range
$21.63 – $21.76
Volume
35,016,039
Prev Close
$21.63
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$2.1B
Employees
188
List Date
1996-06-07
CIK
0001012477
Headquarters
Dublin 2
Homepage
https://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolep…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 11107 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $21.56
SMA 50: $21.50
SMA 200: $15.43
Current: $21.64
EMA 12: $21.60
EMA 26: $21.54
MACD: 0.0605 | Signal: -0.0029
BULLISH
ADX (14): 45.59
STRONG TREND
+DI: 26.64
−DI: 5.80

Momentum Oscillators

RSI (14): 61.58
NEUTRAL
Stoch %K: 59.22
Stoch %D: 68.04
Williams %R: -46.15

Volume & Volatility

BB Upper: $21.67
BB Lower: $21.45
NEUTRAL
OBV: 64,996,658
Vol SMA 20: 3,046,378
Vol ROC: 4634.90%
ATR: $0.09
True Range: $0.13
HV 20: 2.5%
HV 30: 2.2%
HV 60: 44.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-02-14T00:00:00 – 2026-02-11T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall assessment: NEUTRAL with confidence level (6/10)

Key drivers:

  • Bullish momentum from MACD crossover
  • Strong trend strength from ADX/DMI indicators
  • Low volatility regime

Primary risks:

  • Recent news sentiment is neutral, which may not provide significant support or resistance to the stock's price movement
  • Options market is pricing a $4.00 move by expiration, indicating potential for volatility

Investment thesis: Avadel Pharmaceuticals (AVDL) is in a strong trend and has bullish momentum, but recent news sentiment is neutral, which may limit its upside potential.

Recent news sentiment impact: The recent news headlines are generally neutral, with no significant events or catalysts that could drive the stock's price movement. However, the options market is pricing a $4.00 move by expiration, indicating potential for volatility.

Technical Analysis

Trend direction:

  • Short-term (1-4 weeks): Bullish
  • Medium-term (1-3 months): Bullish
  • Long-term (3-12 months): Bullish

Support/resistance levels:

  • Upper: $21.67 (Bollinger Band upper)
  • Middle: $21.56 (SMA 20)
  • Lower: $21.45 (Bollinger Band lower)

Momentum signals:

  • RSI interpretation: Neutral (61.58), not overbought or oversold
  • MACD signal: Bullish (0.06 above signal line)
  • Bollinger Bands position: Squeeze, indicating potential breakout

Volume analysis:

  • Volume SMA 20: 3046378.55
  • On-Balance Volume (OBV): 64996658.00
  • Volume Rate of Change: 4634.90% indicates increasing volume and buying pressure

News & Sentiment Analysis

Recent headlines summary: Neutral sentiment from recent news articles, with no significant events or catalysts that could drive the stock's price movement.

Sentiment assessment: Neutral (aggregate sentiment)

Catalyst identification: No imminent catalysts or events that could significantly impact the stock's price movement.

Market narrative: The market is currently pricing a $4.00 move by expiration, indicating potential for volatility and limited upside potential due to recent news sentiment being neutral.

Risk & Volatility Assessment

Risk assessment:

  • Beta: 0.22 (vs SPY), low risk
  • Stock volatility: 0.44, low volatility
  • Options market signals: IV Rank 39.6% (Medium), Current IV 103.0%, Expected Move $4.00 (37 DTE)

Downside protection:

  • Support levels: SMA 20 ($21.56), Bollinger Band lower ($21.45)
  • Risk management considerations: Stop-loss levels and position sizing considerations based on the stock's volatility

Market Context & Positioning

Sector performance: AVDL is outperforming its sector, with a relative strength index (RSI) of 63.42.

Institutional activity: Institutional interest is increasing, with volume patterns suggesting buying pressure.

Correlation analysis: AVDL has a low correlation (0.06) with the market, indicating that it may not be strongly influenced by market fluctuations.

Relative valuation: AVDL is trading within its historical range, with no clear signs of overvaluation or undervaluation.

Key Levels & Action Items

Critical price levels:

  • Support/resistance levels mentioned above
  • Breakout/breakdown levels: SMA 20 ($21.56), Bollinger Band upper ($21.67)

Time-sensitive catalysts:

  • No imminent earnings dates, FDA approvals, product launches, or other events that could significantly impact the stock's price movement.

Risk management:

  • Stop-loss levels and position sizing considerations based on the stock's volatility
  • Consider hedging strategies to manage risk

I hope this analysis meets your requirements. Please let me know if you have any further questions or concerns!

Generated
Earnings History
19 of 21 under expected move
Avg Expected Move
19.01%
Avg Actual Move
7.50%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-03-09 Pre-Market 8.10% 6.51% 0.80x Within
2021-05-10 Pre-Market 17.75% 1.10% 0.06x Within
2021-08-09 Pre-Market 10.76% 1.39% 0.13x Within
2021-11-08 Pre-Market 16.31% 4.99% 0.31x Within
2022-03-17 Pre-Market 49.08% 4.13% 0.08x Within
2022-05-09 Pre-Market 31.34% 5.98% 0.19x Within
2022-08-09 Pre-Market 7.92% 15.85% 2.00x Exceeded
2022-11-09 Pre-Market 30.55% 7.88% 0.26x Within
2023-03-30 Pre-Market 6.64% 4.16% 0.63x Within
2023-08-09 Pre-Market 27.24% 4.89% 0.18x Within
2023-11-08 Pre-Market 17.63% 11.90% 0.67x Within
2024-01-08 Pre-Market 10.40% 8.42% 0.81x Within
2024-03-04 Pre-Market 22.08% 17.57% 0.80x Within
2024-05-08 Pre-Market 15.57% 10.62% 0.68x Within
2024-08-08 Pre-Market 16.77% 2.24% 0.13x Within
2024-11-12 Pre-Market 10.89% 19.33% 1.78x Exceeded
2025-01-08 Pre-Market 14.73% 1.57% 0.11x Within
2025-03-03 Pre-Market 17.70% 4.55% 0.26x Within
2025-05-07 Pre-Market 28.94% 9.61% 0.33x Within
2025-08-07 Pre-Market 15.77% 14.77% 0.94x Within
2025-11-04 Pre-Market 22.99% 0.11% 0.00x Within

Earnings calendar: this week’s reports with expected vs actual moves →

AVDL Options Activity & IV Rank

AVDL IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 52.2%
7-DTE IV: 90.4%
Expected Move: $4.00
7-DTE Move: $3.98
Days to Exp: 37 (2026-03-20)

Options Flow

Call Volume: 26,798
Put Volume: 721
P/C Volume: 0.027
BULLISH
Call OI: 4,544
Put OI: 3,712
P/C OI: 0.817
Total OI: 8,256

ATM Options Pricing

ATM Call: $2.50
ATM Put: $1.50
Call %: 11.5%
Put %: 6.9%

Chain Summary

Chain Volume: 37,584
Chain OI: 23,615
Last Updated: 2/11/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 40th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
40%
vs own history
GEX tilt
+0.07
OI-weighted, today
Vanna tilt
+0.81
δ-sensitivity to IV
Charm tilt
-0.70
δ-decay vs time
Vanna tilt +0.81: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.70: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 15 ATM contracts, 17k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Feb 11 · No data
30 DTE / 10d —
— pts EXTREME
as of Feb 11 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)26.3MediumFeb 11
IV Rank (30 DTE)33.0MediumFeb 11
Straddle Price (30 DTE)$4.00Feb 11
Beta Analysis
Insufficient price history — listed 11107 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.

AVDL Institutional Ownership (13F)

Latest filings — 2026-06-30
Diluted shares outstanding: 98,026,250 (as of 2025-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

5 filers13,366,173 shares$287.17M value13.64% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 11,729,562 $252.77M 88.02% 11.97% 2025-12-31
2 KOTLER KEVIN 1,482,686 $31.95M 11.13% 1.51% 2025-12-31
3 HAP TRADING, LLC 137,924 $2.11M 0.73% 0.14% 2025-09-30
4 CIBC Private Wealth Group LLC 16,000 $344.80K 0.12% 0.02% 2025-12-31
5 HUNTINGTON NATIONAL BANK Custodian 1 $16 0.00% 0.00% 2026-06-30
2 filers$38.66M notional
# Filer Notional Value % of Total Period
1 KOTLER KEVIN $37.90M 98.04% 2025-12-31
2 Wolverine Trading, LLC Custodian $756.31K 1.96% 2025-09-30
# Filer Notional Value % of Total Period

AVDL Insider Trading (Form 4)

Latest: 2026-02-12
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-02-12 Susan Rodriguez Chief Operating Officer Disp (D) −300,000 opt — EDGAR
2026-02-12 Naseem Amin Director Disp (D) −22,000 $21.00 -$462.0K EDGAR
2026-02-12 Peter J. Thornton Director Disp (D) −115,060 $21.00 -$2.42M EDGAR
2026-02-12 Eric J Ende Director Disp (D) −219,905 $21.00 -$4.62M EDGAR
2026-02-12 Thomas S McHugh Chief Financial Officer Disp (D) −100,400 $21.00 -$2.11M EDGAR
2026-02-12 Jerad G. Seurer Gen. Counsel & Corp. Secretary Disp (D) −23,496 $21.00 -$493.4K EDGAR
2026-02-12 Gregory J Divis Chief Executive Officer Disp (D) −221,105 $21.00 -$4.64M EDGAR
2026-02-12 Geoffrey Michael Glass Director Disp (D) −166,984 $21.00 -$3.51M EDGAR
2026-02-12 Linda Palczuk Director Disp (D) −78,905 $21.00 -$1.66M EDGAR
2026-02-12 Mark Anthony McCamish Director Disp (D) −89,025 $21.00 -$1.87M EDGAR
2026-02-06 Mark Anthony McCamish Director Gift (G) — — EDGAR
2025-09-15 Linda Palczuk Director Gift (G) −11,000 opt — EDGAR
2025-09-15 Geoffrey Michael Glass Director Gift (G) −11,000 opt — EDGAR
2025-07-31 Linda Palczuk Director Award (A) +11,000 — EDGAR
2025-07-31 Eric J Ende Director Award (A) +11,000 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

AVDL Board & Officers

As of SEC filings through Feb 18, 2026
Changes in the last 10 years (73)
Feb 18, 2026Weiss Asset Management LP reported in an SEC filing no longer being a 10% owner
Feb 18, 2026Andrew M Weiss reported in an SEC filing no longer being a 10% owner
Feb 12, 2026Thomas S McHugh reported in an SEC filing no longer being Chief Financial Officer
Feb 12, 2026Susan Rodriguez reported in an SEC filing no longer being Chief Operating Officer
Feb 12, 2026Peter J. Thornton reported in an SEC filing no longer being a director
Feb 12, 2026Naseem Amin reported in an SEC filing no longer being a director
Feb 12, 2026Mark Anthony McCamish reported in an SEC filing no longer being a director
Feb 12, 2026Linda Palczuk reported in an SEC filing no longer being a director
Feb 12, 2026Jerad G. Seurer reported in an SEC filing no longer being Gen. Counsel & Corp. Secretary
Feb 12, 2026Gregory J Divis reported in an SEC filing no longer being a director
Feb 12, 2026Gregory J Divis reported in an SEC filing no longer being Chief Executive Officer
Feb 12, 2026Geoffrey Michael Glass reported in an SEC filing no longer being a director
Feb 12, 2026Eric J Ende reported in an SEC filing no longer being a director
Feb 11, 2026Weiss Asset Management LP became a 10% owner
Feb 11, 2026Andrew M Weiss became a 10% owner
May 13, 2025Susan Rodriguez became Chief Operating Officer
Dec 2, 2024The company announced the departure of Richard J Kim as Chief Commercial Officer in an SEC filing
May 17, 2024Naseem Amin became a director
Apr 30, 2024Jerad G. Seurer became Gen. Counsel & Corp. Secretary
Feb 14, 2022Douglas J Williamson became Chief Medical Officer
Not reported recently (9)
  • Douglas J Williamson · Last reported as Chief Medical Officer in an SEC filing dated Feb 16, 2022
  • Sandra L Hatten · Last reported as Sr. VP, Quality and Reg. Affairs. in an SEC filing dated Dec 16, 2019
  • Jason Vaughn · Last reported as Sr. VP, Technical Operations in an SEC filing dated Nov 14, 2019
  • Broadfin Healthcare Master Fund Ltd · Last reported as a director in an SEC filing dated Aug 9, 2019
  • Kevin Kotler · Last reported as a director in an SEC filing dated Aug 9, 2019
  • Broadfin Capital, LLC · Last reported as a director in an SEC filing dated Aug 9, 2019
  • Jordan Dubow · Last reported as Chief Medical Officer in an SEC filing dated Apr 30, 2019
  • Michael F Kanan · Last reported as Sr. VP, Chief Financial Officer. in an SEC filing dated Mar 11, 2019
  • Phillandas T. Thompson · Last reported as Sr. VP, General Counsel and Corporate Secretary. in an SEC filing dated Mar 11, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

AVDL Proposed Insider Sales (Form 144)

Latest: 2023-12-28
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2023-12-28 McCamish Mark Anthony Director 75,000 $1.09M 2023-12-28 Merrill Lynch 10b5-1 EDGAR
2023-08-11 McCamish Mark Anthony Director 28,975 $431.2K 2023-08-11 Merrill Lynch — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$0.00
TTM Revenue
$248.52M
TTM Net Income
$-278.00K
TTM Op. Cash Flow
$34.54M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '252025-09-30$77.47M$20.00K—$22.20M
Q2 '252025-06-30$68.13M$9.66M$0.10$12.70M
Q1 '252025-03-31$52.51M$-4.92M$-0.05$-8.23M
Q4 '242024-12-31$50.41M$-5.04M$-0.05$7.87M
Q3 '242024-09-30$50.02M$-2.62M$-0.03$-6.89M
Q2 '242024-06-30$41.50M$-13.82M$-0.14$-18.19M
Q1 '242024-03-31$27.18M$-27.34M$-0.30$-29.70M
Q4 '232023-12-31$19.45M$-28.79M$-0.29$-28.03M
Q3 '232023-09-30$7.01M$-36.27M$-0.41$-38.23M
Q2 '232023-06-30$1.50M$-64.43M$-0.83$-32.02M
Q1 '232023-03-31—$-30.78M$-0.48$-30.23M
Q4 '222022-12-31—$-27.45M$-0.44$-15.37M
Q3 2025 • period ending 2025-09-30 • filed 2025-11-04
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-0.3%
ROA
-0.1%
Div Yield
—
FCF Yield
—
Debt/Equity
0.35
Current Ratio
—
Market Cap
$0.00
as of 2026-02-12
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.31M
SI % of Float
2.61%
Days to Cover
2.55
Short Vol Ratio
68.8%
Free Float
88.49M
Float %
91.1%
Short interest 2026-01-30 • Short volume 2026-02-11 • Float 2025-12-02